Public Company News
Visa's Security Roadmap calls time on outdated security as AI-driven scams surge in New Zealand
* Visa is standing up to fraud in New Zealand with bold measures to fight the sharp rise in AI-powered fraud, including real-time analytics, biometric authentication, and mandating a move away from outdated security mechanisms. * New SMB Fraud Prevention Toolkit offers practical guidance, to...
2025-07-04 05:18
5366
Emeren Group Announces North America Management Change and Preliminary Q2 2025 Operating Results
NORWALK, Conn., July 3, 2025 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the
"Company")(www.emeren.com
2025-07-04 04:30
5370
Assembly Launches 'Assembly Control' to Elevate Brand Safety, Suitability, and Campaign Performance in Programmatic Media
First-of-its-kind custom solution prioritizes advertisers' brand safety and campaign performance NEW YORK, July 3, 2025 /PRNewswire/ -- Assembly, a leading media company part of the Stagwell (NASDAQ: STGW) challenger network, announced today the launch of Assembly Control, a proprietary brand s...
2025-07-03 22:00
2506
Creditsafe Realizes 234% ROI with BlackLine, Named Winner of 2025 Nucleus Research ROI Awards
Third-party recognition validates the measurable impact of BlackLine's AI-powered financial operations platform on global finance modernization LOS ANGELES, July 3, 2025 /PRNewswire/ -- BlackLine, Inc. (Nasdaq: BL), the future-ready financial operations platform for the Office of the CFO, today ...
2025-07-03 21:00
4454
NYSE Content advisory: Pre-Market update + June Jobs Report in focus
NEW YORK, July 3, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content advisory: Pre-Market update + June Jobs Report in fo...
2025-07-03 20:56
3818
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results
JILIN, China, July 3, 2025 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines inChina, toda...
2025-07-03 20:30
4426
Fangzhou Tops China's App Store Chart for Healthcare Apps
GUANGZHOU, China, July 3, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, earned the top spot in theJune 2025 China AppStore Healthcare TOP100 Free APP Rankings with its Fangzhou Online Pharmacy App, according to a report by ...
2025-07-03 18:43
2110
Yunji Announces Changes in Management
HANGZHOU, China, July 3, 2025 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced that Mr.Yeqing Cui, has resigned as Senior Financial Director and finance in charge of the Company for personal reasons, effecti...
2025-07-03 18:30
2041
So-Young Regains Compliance with Nasdaq Minimum Bid Price Requirement
BEIJING, July 3, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform inChina connecting consumers with online services and offline treatments, today announced that it has received a written compliance notification f...
2025-07-03 17:00
4038
Akeso's First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in 'IO+ADC' 2.0 Strategy
HONG KONG, July 3, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a bispecific Antibody-Drug Conjugate (ADC) targeting Trop2 and Nectin4. AK146D1 is Akeso's first bispec...
2025-07-03 14:46
2188
Invitation to presentation of EQT AB's Half-year Report 2025
STOCKHOLM, July 3, 2025 /PRNewswire/ -- EQT AB's Half-year Report 2025 will be published on Thursday 17 July 2025 at approximately 07:00 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session. The presentation and a video link for the webcast will be ...
2025-07-03 13:41
1820
J&V Energy Wins Dual Honors at 2025 Asia Responsible Enterprise Awards for Environmental Leadership and Community Impact
BANGKOK, July 3, 2025 /PRNewswire/ -- J&V Energy Technology (6869-TW), a leader in integrated sustainable development and circular economy solutions in Taiwan, hasearned global recognition for its sustainable initiatives, securing two prestigious awards at the 2025 Asia Responsible Enterprise Awa...
2025-07-03 11:18
2434
World-Leading Breakthrough! Risen Energy's HJT Modules Hit Average 740Wp Mass Production with Record 26.61% Cell Efficiency
NINGBO, China, July 3, 2025 /PRNewswire/ -- A milestone in global heterojunction (HJT) photovoltaic technology! Risen Energy Co., Ltd. (Stock Code: 300118) today announced its self-developed Hyper-ion HJT modules have achieved a groundbreaking740Wp average mass-production power, setting a new in...
2025-07-03 10:00
3242
Eye Level Malaysia Ignites Learning Joy with Mid-Year Promo & Exclusive Block Sets!
KUALA LUMPUR, Malaysia, July 3, 2025 /PRNewswire/ -- Eye Level Malaysia, a leading name in supplemental education, is thrilled to announce its special Mid-Year Promo, designed to re-energize children's passion for learning as the school year progresses. From July 1st to July 31st, 2025, all new e...
2025-07-03 08:59
2712
Dizal's ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
* ZEGFROVY is the only approved targeted oral treatment for NSCLC with EGFR exon20ins * Approval follows the U.S. FDA's Priority Review and is supported by the pivotal WU-KONG1 Part B study, in which ZEGFROVY demonstrated statistically significant and clinically meaningfulbenefits to patien...
2025-07-03 08:08
2178
Blokees Becomes Exclusive Strategic Partner of "Journey of Light: A Glimpse into Ultraman's 60th Anniversary" Exhibition
SHANGHAI, July 3, 2025 /PRNewswire/ -- On July 2nd, the much-anticipated exhibition "Journey of Light: A Glimpse into Ultraman's 60th Anniversary" hosted its media preview day inShanghai. The event will officially open to the public onJuly 5th. The Chinese Assembly Character Toys brand Blokees is...
2025-07-03 08:00
2880
USI Delivers Full-System JDM Design Services for Level 10 AI Edge Server Platform
SHANGHAI, July 3, 2025 /PRNewswire/ -- USI, Universal Scientific Industrial (Shanghai) Co., Ltd., a global leader in electronic design and manufacturing services, announced the successful delivery of a Level 10 full-system Joint Design Manufacturing (JDM) project, supporting a global customer in ...
2025-07-03 07:30
2702
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001
Highlights: * Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement * Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, providing exclusive access to an extensive package of non-clinical studies and manufacturing da...
2025-07-03 07:09
2189
Ascletis Announces First Participants with Obesity or Overweight Dosed in a U.S. 13-week Phase IIa Study of Small Molecule Oral GLP-1R Agonist ASC30
- First participants with obesity or overweight with at least one weight-r elatedcomorbidity have been dosed in a U.S. 13-week Phase IIa study of small m oleculeoral GLP-1 receptor agonist ASC30. - ASC30 oral once-daily tablet demonstrated up to 6.5% placebo-adjusted mean body weight reduction f...
2025-07-03 07:00
2114
Ventia Partners with DXC to Revolutionise Bid Writing with AI-powered Solution
Tendia solution will cut time taken for drafting initial bid responses for major infrastructure contracts from days to minutes SYDNEY, Australia, July 3, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a Fortune 500 global technology services provider, today announced the successful deployment...
2025-07-03 05:00
1951
Week's Top Stories
Most Reposted
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 278 media titles]
2025-12-26 12:55Vietnam's Newest EDM Destination, APLUS SAIGON, Debuts With Star-Studded Soft Opening Weekends Featuring Dombresky and Argy
[Picked up by 273 media titles]
2025-12-30 20:12
ACEN completes transition to 100% renewable energy
[Picked up by 273 media titles]
2025-12-29 18:53iQIYI LAND Yangzhou to Open on February 8, Marking New Chapter in China's Immersive Entertainment Scene
[Picked up by 265 media titles]
2026-01-01 10:00
CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 263 media titles]
2025-12-29 09:00
